Global DNA methylation and one-carbon metabolism gene polymorphisms and the risk of breast cancer in the Sister Study

Carcinogenesis

Volumn 35, Issue 2, 2014, Pages 333-338

  DeRoo, Lisa A ^a,b   Bolick, Sophia C E ^a   Xu, Zongli ^a   Umbach, David M ^a   Shore, David ^c   Weinberg, Clarice R ^a   Sandler, Dale P ^a   Taylor, Jack A ^a  

^a NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

^b UNIVERSITY OF BERGEN   (Norway)

^c WESTAT   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARYLDIALKYLPHOSPHATASE 1; DNA METHYLTRANSFERASE 3A; DNA METHYLTRANSFERASE 3B; METHIONINE SYNTHASE REDUCTASE; ORAL CONTRACEPTIVE AGENT;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; BLOOD SAMPLING; BODY MASS; BREAST CANCER; CANCER PATIENT; CANCER RISK; CARBON METABOLISM; CASE CONTROL STUDY; CONTROLLED STUDY; DNA METHYLATION; EDUCATIONAL STATUS; FEMALE; GENE FREQUENCY; GENE LINKAGE DISEQUILIBRIUM; GENETIC ASSOCIATION; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MIDDLE AGED; PREGNANCY; PRIORITY JOURNAL; PROSPECTIVE STUDY; PYROSEQUENCING; RETROSPECTIVE STUDY; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; AGED; BREAST NEOPLASMS; CARBON; CASE-CONTROL STUDIES; DNA METHYLATION; FEMALE; FOLLOW-UP STUDIES; GENOME, HUMAN; HUMANS; LONG INTERSPERSED NUCLEOTIDE ELEMENTS; MIDDLE AGED; NEOPLASM STAGING; POLYMORPHISM, SINGLE NUCLEOTIDE; PROGNOSIS; PROSPECTIVE STUDIES; RISK FACTORS; TUMOR MARKERS, BIOLOGICAL;

EID: 84893370515     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgt342     Document Type: Article

References (50)

1. Dumitrescu,R.G. (2012) DNA methylation and histone modifications in breast cancer. Methods Mol. Biol., 863, 35-45.
2. Esteller,M. et al. (2001) DNA methylation patterns in hereditary human cancers mimic sporadic tumorigenesis. Hum. Mol. Genet., 10, 3001-3007.
3. Estécio,M.R. et al. (2007) LINE-1 hypomethylation in cancer is highly variable and inversely correlated with microsatellite instability. PLoS ONE, 2, e399.
4. Chalitchagorn,K. et al. (2004) Distinctive pattern of LINE-1 methylation level in normal tissues and the association with carcinogenesis. Oncogene, 23, 8841-8846.
5. Weisenberger,D.J. et al. (2005) Analysis of repetitive element DNA methylation by MethyLight. Nucleic Acids Res., 33, 6823-6836.
6. Yang,A.S. et al. (2004) A simple method for estimating global DNA methylation using bisulfite PCR of repetitive DNA elements. Nucleic Acids Res., 32, e38.
7. Kochanek,S. et al. (1993) DNA methylation in the Alu sequences of diploid and haploid primary human cells. EMBO J., 12, 1141-1151.
8. Schmid,C.W. (1998) Does SINE evolution preclude Alu function? Nucleic Acids Res., 26, 4541-4550.
9. Soares,J. et al. (1999) Global DNA hypomethylation in breast carcinoma: correlation with prognostic factors and tumor progression. Cancer, 85, 112-118.
10. van Hoesel,A.Q. et al. (2012) Hypomethylation of LINE-1 in primary tumor has poor prognosis in young breast cancer patients: a retrospective cohort study. Breast Cancer Res. Treat., 134, 1103-1114.
11. Jackson,K. et al. (2004) DNA hypomethylation is prevalent even in lowgrade breast cancers. Cancer Biol. Ther., 3, 1225-1231.
12. Woo,H.D. et al. (2012) Global DNA hypomethylation in peripheral blood leukocytes as a biomarker for cancer risk: a meta-analysis. PLoS ONE, 7, e34615.
13. Wilhelm,C.S. et al. (2010) Implications of LINE1 methylation for bladder cancer risk in women. Clin. Cancer Res., 16, 1682-1689.
14. Cash,H.L. et al. (2012) LINE-1 hypomethylation is associated with bladder cancer risk among nonsmoking Chinese. Int. J. Cancer, 130, 1151-1159.
15. Hsiung,D.T. et al. (2007) Global DNA methylation level in whole blood as a biomarker in head and neck squamous cell carcinoma. Cancer Epidemiol. Biomarkers Prev., 16, 108-114.
16. Choi,J.Y. et al. (2009) Association between global DNA hypomethylation in leukocytes and risk of breast cancer. Carcinogenesis, 30, 1889-1897.
17. Xu,X. et al. (2012) DNA methylation in peripheral blood measured by LUMA is associated with breast cancer in a population-based study. FASEB J., 26, 2657-2666.
18. Flanagan,J.M. et al. (2009) Gene-body hypermethylation of ATM in peripheral blood DNA of bilateral breast cancer patients. Hum. Mol. Genet., 18, 1332-1342.
19. Cho,Y.H. et al. (2010) Aberrant promoter hypermethylation and genomic hypomethylation in tumor, adjacent normal tissues and blood from breast cancer patients. Anticancer Res., 30, 2489-2496.
20. Wu,H.C. et al. (2012) Repetitive element DNA methylation levels in white blood cell DNA from sisters discordant for breast cancer from the New York site of the Breast Cancer Family Registry. Carcinogenesis, 33, 1946-1952.
21. Bestor,T.H. (2000) The DNA methyltransferases of mammals. Hum. Mol. Genet., 9, 2395-2402.
22. Friso,S. et al. (2002) A common mutation in the 5,10-methylenetetrahydrofolate reductase gene affects genomic DNA methylation through an interaction with folate status. Proc. Natl Acad. Sci. USA, 99, 5606-5611.
23. Chen,J. et al. (2005) One-carbon metabolism, MTHFR polymorphisms, and risk of breast cancer. Cancer Res., 65, 1606-1614.
24. Dumitrescu,R.G. et al. (2008) DNA hypermethylation phenotypes and one carbon metabolism genetic variants in breast tissues from normal healthy women. Vol. 17. Cancer Epidemiol. Biomarkers Prev., 32nd Annual Meeting, American Society of Preventive Oncology, Bethesda, MD, pp. 460.
25. Lissowska,J. et al. (2007) Genetic polymorphisms in the one-carbon metabolism pathway and breast cancer risk: a population-based case-control study and meta-analyses. Int. J. Cancer, 120, 2696-2703.
26. Marian,C. et al. (2008) Global DNA methylation level in normal breast tissue: associations with demographics, lifestyle exposures and one carbon metabolism genes SNPs. Vol. 17. Cancer Epidemiol. Biomarkers Prev., 32nd Annual Meeting, American Society of Preventive Oncology, Bethesda, MD, pp. 463.
27. Stevens,V.L. et al. (2007) Association of polymorphisms in one-carbon metabolism genes and postmenopausal breast cancer incidence. Cancer Epidemiol. Biomarkers Prev., 16, 1140-1147.
28. Suzuki,T. et al. (2008) One-carbon metabolism-related gene polymorphisms and risk of breast cancer. Carcinogenesis, 29, 356-362.
29. Xu,X. et al. (2007) Polymorphisms of one-carbon-metabolizing genes and risk of breast cancer in a population-based study. Carcinogenesis, 28, 1504-1509.
30. Terry,M.B. et al. (2008) Genomic DNA methylation among women in a multiethnic New York City birth cohort. Cancer Epidemiol. Biomarkers Prev., 17, 2306-2310.
31. Xu,Z. et al. (2009) SNPinfo: integrating GWAS and candidate gene information into functional SNP selection for genetic association studies. Nucleic Acids Res., 37(Web Server issue), W600-W605.
32. Hunter,D.J. et al. (2007) A genome-wide association study identifies alleles in FGFR2 associated with risk of sporadic postmenopausal breast cancer. Nat. Genet., 39, 870-874.
33. Therneau,T.M. et al. (1999) Computing the Cox model for case cohort designs. Lifetime Data Anal., 5, 99-112.
34. Prentice,R.L. et al. (1988) Aspects of the use of relative risk models in the design and analysis of cohort studies and prevention trials. Stat. Med., 7, 275-287.
35. Irahara,N. et al. (2010) Precision of pyrosequencing assay to measure LINE-1 methylation in colon cancer, normal colonic mucosa, and peripheral blood cells. J. Mol. Diagn., 12, 177-183.
36. Kulis,M. et al. (2010) DNA methylation and cancer. Adv. Genet., 70, 27-56.
37. Xu,Z. et al. (2013) Epigenome-wide association study of breast cancer using prospectively collected sister study samples. J. Natl Cancer Inst., 105, 694-700.
38. Nelson,H.H. et al. (2011) Global methylation in exposure biology and translational medical science. Environ. Health Perspect., 119, 1528-1533.
39. Herceg,Z. et al. (2010) Introduction: epigenetics and cancer. Adv. Genet., 70, 1-23.
40. Tajuddin,S.M. et al.; Spanish Bladder Cancer/EPICURO Study Investigators. (2013) Genetic and non-genetic predictors of LINE-1 methylation in leukocyte DNA. Environ. Health Perspect., 121, 650-656.
41. White,A.J. et al. (2013) Recreational and household physical activity at different time points and DNA global methylation. Eur. J. Cancer, 49, 2199-2206.
42. Koestler,D.C. et al. (2012) Peripheral blood immune cell methylation profiles are associated with nonhematopoietic cancers. Cancer Epidemiol. Biomarkers Prev., 21, 1293-1302.
43. Yamada,K. et al. (2001) Effects of common polymorphisms on the properties of recombinant human methylenetetrahydrofolate reductase. Proc. Natl Acad. Sci. USA, 98, 14853-14858.
44. Frosst,P. et al. (1995) A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nat. Genet., 10, 111-113.
45. van der Put,N.M. et al. (1998) A second common mutation in the methylenetetrahydrofolate reductase gene: an additional risk factor for neuraltube defects? Am. J. Hum. Genet., 62, 1044-1051.
46. Ohnami,S. et al. (2008) His595Tyr polymorphism in the methionine synthase reductase (MTRR) gene is associated with pancreatic cancer risk. Gastroenterology, 135, 477-488.
47. Levine,A.J. et al. (2011) Variation in folate pathway genes and distal colorectal adenoma risk: a sigmoidoscopy-based case-control study. Cancer Causes Control, 22, 541-552.
48. Hussein,Y.M. et al. (2011) Association of L55M and Q192R polymorphisms in paraoxonase 1 (PON1) gene with breast cancer risk and their clinical significance. Mol. Cell. Biochem., 351, 117-123.
49. Liu,C. et al. (2011) Polymorphisms in three obesity-related genes (LEP, LEPR, and PON1) and breast cancer risk: a meta-analysis. Tumour Biol., 32, 1233-1240.
50. Naidu,R. et al. (2010) Genetic polymorphisms of paraoxonase 1 (PON1) gene: association between L55M or Q192R with breast cancer risk and clinico-pathological parameters. Pathol. Oncol. Res., 16, 533-540.